Nitrato de circonio (IV) pentahidratado, mínimo 98 %, puro, 100 g, envase de plástico.

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(3-BROMOPHENYL)BUTANOIC ACID, 95%, 1g

8-Hydroxyquinoline-N-oxide, 97.0%, 1g

2-(Ethoxycarbonyl)phenylboronic Acid (contains varying amounts of Anhydride)5g

Yoduro de acetiltiocolina, mínimo 99 %, para bioquímica, 10 g, envase de vidrio

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)oct-7-enoic acid, 95.0%, 5g

Recipiente de cristalización ROTILABO® sin pico, 100 ml, 70 mm, 10 Unidad(es)

trans-Aconitic acid, 98%, 100g

(3aR,8aS)-2-(Pyrimidin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 1g

(1S,2R)-2-Fluorocyclopropan-1-amine hydrochloride, 98%, 250mg

((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide, 97%, 100g

ETHYL 5-CHLOROQUINOLINE-3-CARBOXYLATE, 95.0%, 100mg

(2,6-dinitro-4-(trifluoromethyl)phenyl)glycine, 95.0%, 500mg